BNOV Performance — Innovator U.S. Equity Buffer ETF - November
Data updated: 2026-09-28
BNOV returned +7.97% year to date and +14.25% over one year to Jul 2026. Annualised returns are +11.10% over 3 years and +8.51% over 5 years. The fund trailed its US Blend category average: $100 invested three years ago grew to $137, against $147 for the category, and to $114 over one year, against $120. Volatility over the past three years was 8.95% a year. In the 12 months to Jul 2026 the fund took in a net $48.5M, and assets reached $207.48M.
BNOV Growth of $100
What $100 invested in Innovator U.S. Equity Buffer ETF - November grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Blend category average over the same months.
| Period | BNOV | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $114 | $120 |
| 3 years (Aug 2023 – Jul 2026) | $137 | $147 |
| 5 years (Aug 2021 – Jul 2026) | $150 | $143 |
| Since data start (Feb 2020 – Jul 2026) | $179 | $169 |
BNOV Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.97% |
| 1 year | +14.25% |
| 3 years (annualised) | +11.10% |
| 5 years (annualised) | +8.51% |
BNOV Annual Returns
Calendar-year total returns of Innovator U.S. Equity Buffer ETF - November, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +7.97% |
| 2025 | +12.95% |
| 2024 | +12.70% |
| 2023 | +17.26% |
| 2022 | −9.46% |
| 2021 | +10.38% |
| 2020 (Feb–Dec) | +11.34% |
BNOV Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.1% | −0.5% | −3.7% | +7.7% | +3.5% | −0.4% | +0.4% | — | — | — | — | — |
| 2025 | +1.8% | −0.7% | −3.9% | −0.5% | +4.7% | +3.7% | +1.9% | +1.6% | +2.0% | +1.3% | +0.4% | +0.3% |
| 2024 | +1.2% | +2.1% | +1.1% | −0.6% | +2.2% | +0.9% | +0.5% | +0.9% | +0.6% | +0.5% | +3.8% | −1.1% |
| 2023 | +5.2% | −2.1% | +3.0% | +1.4% | +0.3% | +5.7% | +3.0% | −1.6% | −4.9% | −2.3% | +6.4% | +2.6% |
| 2022 | −3.0% | −2.1% | +2.6% | −6.0% | +0.8% | −5.2% | +6.6% | −2.1% | −7.6% | +7.3% | +4.4% | −4.2% |
| 2021 | −1.2% | +1.8% | +3.2% | +1.3% | +0.8% | +0.7% | +0.3% | +0.8% | −0.1% | +0.3% | −1.0% | +3.1% |
| 2020 | — | −5.5% | −9.7% | +9.2% | +4.2% | +0.8% | +4.1% | +3.5% | −1.3% | −1.8% | +7.5% | +1.4% |
BNOV Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 8.95%
- 3-year Sharpe ratio: 0.74 (vs 4.5% risk-free rate)
- Best month: +7.71% (Apr 2026)
- Worst month: −4.89% (Sep 2023)
BNOV Fund Flows
Monthly money in and out of Innovator U.S. Equity Buffer ETF - November, from SEC Form N-PORT.
- 12-month net flow: $48.5M
- 12-month gross sales (incl. reinvestments): $251.1M
- Sales ÷ redemptions: 1.24×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $0 | $4.8M | −$4.8M |
| Jun 2026 | $0 | $3.6M | −$3.6M |
| May 2026 | $11.7M | $36.4M | −$24.7M |
| Apr 2026 | $6.7M | $0 | $6.7M |
| Mar 2026 | $1.1M | $0 | $1.1M |
| Feb 2026 | $2.3M | $0 | $2.3M |
| Jan 2026 | $2.2M | $13.4M | −$11.2M |
| Dec 2025 | $6.6M | $3.3M | $3.3M |
| Nov 2025 | $77.8M | $2.2M | $75.6M |
| Oct 2025 | $142.7M | $134.7M | $8.0M |
| Sep 2025 | $0 | $2.2M | −$2.2M |
| Aug 2025 | $0 | $2.1M | −$2.1M |
BNOV Assets Under Management
Net assets of Innovator U.S. Equity Buffer ETF - November by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $207.48M |
| 2026-04-30 | $232.94M |
| 2026-01-31 | $215.61M |
| 2025-10-31 | $143.36M |
| 2025-07-31 | $133.31M |
| 2025-04-30 | $150.10M |
| 2025-01-31 | $173.25M |
| 2024-10-31 | $98.64M |
| 2024-07-31 | $102.42M |
| 2024-04-30 | $102.41M |
| 2024-01-31 | $110.42M |
| 2023-10-31 | $83.95M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.